Literature DB >> 25278269

Reversion-Inducing-Cysteine-Rich Protein With Kazal Motifs (RECK) Gene Single Nucleotide Polymorphism With Hepatocellular Carcinoma: A Case-Control Study.

Dina M Rasheed Bahgat1, Rasha Mohamad Hosny Shahin1, Nada Nasr Makar1, Ashraf Omar Abdel Aziz2, Shereen Shoukry Hunter3.   

Abstract

BACKGROUND: The reversion-inducing-cysteine-rich protein with kazal motifs (RECK) gene is a transformation suppressor gene that can negatively regulate matrix metalloproteinases (MMPs) and inhibit tumor invasion, angiogenesis, and metastasis. So, the aim of this study was to analyze the effect of RECK gene rs 11788747 single nucleotide polymorphism (SNP) on hepatocellular carcinoma (HCC) susceptibility and its relation to various clinical and laboratory data of the patients.
METHODS: This is a case-control study including 200 HCC patients and 200 healthy controls. RECK rs 11788747 genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
RESULTS: RECK rs 11788747 A/G and G/G genotypes frequencies were significantly higher in HCC patients compared to the healthy controls. The HCC patients possessing at least one polymorphic G allele were significantly at a higher risk of developing lymph nodes involvement and distant metastasis.
CONCLUSION: This study revealed the role of RECK rs 11788747 SNP in HCC in Egyptian patients, which consequently might be used as a prognostic tool and could be added to its therapeutic strategies.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Egypt; HCC; RECK; rs 11788747

Mesh:

Substances:

Year:  2014        PMID: 25278269      PMCID: PMC6807138          DOI: 10.1002/jcla.21806

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  14 in total

1.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2012-04       Impact factor: 25.083

2.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

3.  The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.

Authors:  J Oh; R Takahashi; S Kondo; A Mizoguchi; E Adachi; R M Sasahara; S Nishimura; Y Imamura; H Kitayama; D B Alexander; C Ide; T P Horan; T Arakawa; H Yoshida; S Nishikawa; Y Itoh; M Seiki; S Itohara; C Takahashi; M Noda
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

4.  MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer.

Authors:  Mark Bloomston; Alexis Shafii; Emmanuel E Zervos; Amyn Rojiani; Alexander S Rosemurgy
Journal:  J Surg Res       Date:  2002-01       Impact factor: 2.192

Review 5.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

6.  The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.

Authors:  Taku Takeuchi; Michiyoshi Hisanaga; Mitsuo Nagao; Naoya Ikeda; Hisao Fujii; Fumikazu Koyama; Tomohide Mukogawa; Hiroshi Matsumoto; Shunya Kondo; Chiaki Takahashi; Makoto Noda; Yoshiyuki Nakajima
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

Review 7.  RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.

Authors:  Jonathan C M Clark; David M Thomas; Peter F M Choong; Crispin R Dass
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

Review 8.  Recklessness as a hallmark of aggressive cancer.

Authors:  Makoto Noda; Chiaki Takahashi
Journal:  Cancer Sci       Date:  2007-08-28       Impact factor: 6.716

Review 9.  Matrix metalloproteases in head and neck cancer.

Authors:  Eben L Rosenthal; Lynn M Matrisian
Journal:  Head Neck       Date:  2006-07       Impact factor: 3.147

10.  Effect of RECK gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.

Authors:  Tsung-Te Chung; Chao-Bin Yeh; Yi-Ching Li; Shih-Chi Su; Ming-Hsien Chien; Shun-Fa Yang; Yi-Hsien Hsieh
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

View more
  3 in total

1.  Circular RNA 0068669 as a new biomarker for hepatocellular carcinoma metastasis.

Authors:  Ting Yao; Qingqing Chen; Zhouwei Shao; Zhihua Song; Liyun Fu; Bingxiu Xiao
Journal:  J Clin Lab Anal       Date:  2018-05-21       Impact factor: 2.352

2.  Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways.

Authors:  Andrea Ferrigno; Laura G Di Pasqua; Giuseppina Palladini; Clarissa Berardo; Roberta Verta; Plinio Richelmi; Stefano Perlini; Debora Collotta; Massimo Collino; Mariapia Vairetti
Journal:  Biomolecules       Date:  2020-05-11

Review 3.  The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH.

Authors:  Ryan J Dashek; Connor Diaz; Bysani Chandrasekar; R Scott Rector
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-20       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.